Similar Articles
991 Conversion hepatectomy for hepatocellular carcinoma with main portal vein tumour thrombus after lenvatinib treatment: A case report
992 Apolipoprotein E polymorphism influences orthotopic liver transplantation outcomes in patients with hepatitis C virus-induced liver cirrhosis
993 Long-term follow-up of cumulative incidence of hepatocellular carcinoma in hepatitis B virus patients without antiviral therapy
994 Chronic renal dysfunction in cirrhosis: A new frontier in hepatology
995 Noninvasive markers of liver steatosis and fibrosis after liver transplantation – Where do we stand?
996 Bidirectional link between diabetes mellitus and coronavirus disease 2019 leading to cardiovascular disease: A narrative review
997 Radiotherapy as an immune checkpoint blockade combination strategy for hepatocellular carcinoma
998 Huanglian decoction suppresses the growth of hepatocellular carcinoma cells by reducing CCNB1 expression
999 Ursodeoxycholic acid as a means of preventing atherosclerosis, steatosis and liver fibrosis in patients with nonalcoholic fatty liver disease
1000 Short-term outcomes of radiofrequency ablation for hepatocellular carcinoma using cone-beam computed tomography for planning and image guidance
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA